ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rotavirus Vaccines Market Insights, Forecast to 2030
Published Date: September 2024
|
Report Code: QYRE-Auto-7F2159
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rotavirus Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rotavirus Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-7F2159
Report
September 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bharat Biotech
Merck& Co. Inc
GlaxoSmithKline PLC
Lanzhou Institute of Biological
Bharat Biotech International Limited

Rotavirus Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rotavirus Vaccines Market

Rotavirus Vaccines Market

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Rotavirus Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rotavirus Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rotavirus Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rotavirus Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rotavirus Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rotavirus Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Rotavirus Vaccines Market Report

Report Metric Details
Report Name Rotavirus Vaccines Market
CAGR 5%
Segment by Type
  • Rotarix
  • RotaTeq
  • Rotavac
  • Rotavin-M1
  • Lanzhou lamb
  • Others
Segment by Application
  • Adult
  • Pediatric
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Rotavirus Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rotavirus Vaccines sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rotavirus Vaccines Market report?

Ans: The main players in the Rotavirus Vaccines Market are GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited

What are the Application segmentation covered in the Rotavirus Vaccines Market report?

Ans: The Applications covered in the Rotavirus Vaccines Market report are Adult, Pediatric

What are the Type segmentation covered in the Rotavirus Vaccines Market report?

Ans: The Types covered in the Rotavirus Vaccines Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others

1 Study Coverage
1.1 Rotavirus Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Rotavirus Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market by Application
1.3.1 Global Rotavirus Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Pediatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rotavirus Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global Rotavirus Vaccines Revenue by Region
2.2.1 Global Rotavirus Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Rotavirus Vaccines Revenue by Region (2019-2024)
2.2.3 Global Rotavirus Vaccines Revenue by Region (2025-2030)
2.2.4 Global Rotavirus Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Rotavirus Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Rotavirus Vaccines Sales by Region
2.4.1 Global Rotavirus Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Rotavirus Vaccines Sales by Region (2019-2024)
2.4.3 Global Rotavirus Vaccines Sales by Region (2025-2030)
2.4.4 Global Rotavirus Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rotavirus Vaccines Sales by Manufacturers
3.1.1 Global Rotavirus Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Rotavirus Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rotavirus Vaccines in 2023
3.2 Global Rotavirus Vaccines Revenue by Manufacturers
3.2.1 Global Rotavirus Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Rotavirus Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rotavirus Vaccines Revenue in 2023
3.3 Global Key Players of Rotavirus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Rotavirus Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rotavirus Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rotavirus Vaccines Sales by Type
4.1.1 Global Rotavirus Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Rotavirus Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Rotavirus Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Rotavirus Vaccines Revenue by Type
4.2.1 Global Rotavirus Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Rotavirus Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Rotavirus Vaccines Price by Type
4.3.1 Global Rotavirus Vaccines Price by Type (2019-2024)
4.3.2 Global Rotavirus Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Rotavirus Vaccines Sales by Application
5.1.1 Global Rotavirus Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Rotavirus Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Rotavirus Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Rotavirus Vaccines Revenue by Application
5.2.1 Global Rotavirus Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Rotavirus Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Rotavirus Vaccines Price by Application
5.3.1 Global Rotavirus Vaccines Price by Application (2019-2024)
5.3.2 Global Rotavirus Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Rotavirus Vaccines Market Size by Type
6.1.1 US & Canada Rotavirus Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Rotavirus Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Rotavirus Vaccines Market Size by Application
6.2.1 US & Canada Rotavirus Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Rotavirus Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Rotavirus Vaccines Market Size by Country
6.3.1 US & Canada Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Rotavirus Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada Rotavirus Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rotavirus Vaccines Market Size by Type
7.1.1 Europe Rotavirus Vaccines Sales by Type (2019-2030)
7.1.2 Europe Rotavirus Vaccines Revenue by Type (2019-2030)
7.2 Europe Rotavirus Vaccines Market Size by Application
7.2.1 Europe Rotavirus Vaccines Sales by Application (2019-2030)
7.2.2 Europe Rotavirus Vaccines Revenue by Application (2019-2030)
7.3 Europe Rotavirus Vaccines Market Size by Country
7.3.1 Europe Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Rotavirus Vaccines Sales by Country (2019-2030)
7.3.3 Europe Rotavirus Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rotavirus Vaccines Market Size
8.1.1 China Rotavirus Vaccines Sales (2019-2030)
8.1.2 China Rotavirus Vaccines Revenue (2019-2030)
8.2 China Rotavirus Vaccines Market Size by Application
8.2.1 China Rotavirus Vaccines Sales by Application (2019-2030)
8.2.2 China Rotavirus Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rotavirus Vaccines Market Size by Type
9.1.1 Asia Rotavirus Vaccines Sales by Type (2019-2030)
9.1.2 Asia Rotavirus Vaccines Revenue by Type (2019-2030)
9.2 Asia Rotavirus Vaccines Market Size by Application
9.2.1 Asia Rotavirus Vaccines Sales by Application (2019-2030)
9.2.2 Asia Rotavirus Vaccines Revenue by Application (2019-2030)
9.3 Asia Rotavirus Vaccines Sales by Region
9.3.1 Asia Rotavirus Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Rotavirus Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Rotavirus Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rotavirus Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Rotavirus Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Rotavirus Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Rotavirus Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bharat Biotech Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Information
11.2.2 Merck & Co., Inc Overview
11.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck & Co., Inc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co., Inc Recent Developments
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Information
11.3.2 GlaxoSmithKline plc Overview
11.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 GlaxoSmithKline plc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline plc Recent Developments
11.4 Lanzhou Institute of Biological
11.4.1 Lanzhou Institute of Biological Company Information
11.4.2 Lanzhou Institute of Biological Overview
11.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute of Biological Recent Developments
11.5 Bharat Biotech International Limited
11.5.1 Bharat Biotech International Limited Company Information
11.5.2 Bharat Biotech International Limited Overview
11.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Bharat Biotech International Limited Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bharat Biotech International Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rotavirus Vaccines Industry Chain Analysis
12.2 Rotavirus Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rotavirus Vaccines Production Mode & Process
12.4 Rotavirus Vaccines Sales and Marketing
12.4.1 Rotavirus Vaccines Sales Channels
12.4.2 Rotavirus Vaccines Distributors
12.5 Rotavirus Vaccines Customers
13 Market Dynamics
13.1 Rotavirus Vaccines Industry Trends
13.2 Rotavirus Vaccines Market Drivers
13.3 Rotavirus Vaccines Market Challenges
13.4 Rotavirus Vaccines Market Restraints
14 Key Findings in The Global Rotavirus Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Bharat Biotech
Merck& Co. Inc
GlaxoSmithKline PLC
Lanzhou Institute of Biological
Bharat Biotech International Limited
List of Tables
    Table 1. Global Rotavirus Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Rotarix
    Table 3. Major Manufacturers of RotaTeq
    Table 4. Major Manufacturers of Rotavac
    Table 5. Major Manufacturers of Rotavin-M1
    Table 6. Major Manufacturers of Lanzhou lamb
    Table 7. Major Manufacturers of Others
    Table 8. Global Rotavirus Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Rotavirus Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Rotavirus Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 11. Global Rotavirus Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 12. Global Rotavirus Vaccines Revenue Market Share by Region (2019-2024)
    Table 13. Global Rotavirus Vaccines Revenue Market Share by Region (2025-2030)
    Table 14. Global Rotavirus Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 15. Global Rotavirus Vaccines Sales by Region (2019-2024) & (K Units)
    Table 16. Global Rotavirus Vaccines Sales by Region (2025-2030) & (K Units)
    Table 17. Global Rotavirus Vaccines Sales Market Share by Region (2019-2024)
    Table 18. Global Rotavirus Vaccines Sales Market Share by Region (2025-2030)
    Table 19. Global Rotavirus Vaccines Sales by Manufacturers (2019-2024) & (K Units)
    Table 20. Global Rotavirus Vaccines Sales Share by Manufacturers (2019-2024)
    Table 21. Global Rotavirus Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 22. Global Rotavirus Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 23. Global Key Players of Rotavirus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 24. Rotavirus Vaccines Price by Manufacturers 2019-2024 (USD/Unit)
    Table 25. Global Rotavirus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2023)
    Table 27. Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Base Distribution and Headquarters
    Table 28. Global Key Manufacturers of Rotavirus Vaccines, Product Offered and Application
    Table 29. Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 32. Global Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 33. Global Rotavirus Vaccines Sales Share by Type (2019-2024)
    Table 34. Global Rotavirus Vaccines Sales Share by Type (2025-2030)
    Table 35. Global Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 36. Global Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 37. Global Rotavirus Vaccines Revenue Share by Type (2019-2024)
    Table 38. Global Rotavirus Vaccines Revenue Share by Type (2025-2030)
    Table 39. Rotavirus Vaccines Price by Type (2019-2024) & (USD/Unit)
    Table 40. Global Rotavirus Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 41. Global Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 42. Global Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 43. Global Rotavirus Vaccines Sales Share by Application (2019-2024)
    Table 44. Global Rotavirus Vaccines Sales Share by Application (2025-2030)
    Table 45. Global Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 46. Global Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 47. Global Rotavirus Vaccines Revenue Share by Application (2019-2024)
    Table 48. Global Rotavirus Vaccines Revenue Share by Application (2025-2030)
    Table 49. Rotavirus Vaccines Price by Application (2019-2024) & (USD/Unit)
    Table 50. Global Rotavirus Vaccines Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 51. US & Canada Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 52. US & Canada Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 53. US & Canada Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 54. US & Canada Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 55. US & Canada Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 56. US & Canada Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 57. US & Canada Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 58. US & Canada Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 59. US & Canada Rotavirus Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 60. US & Canada Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 61. US & Canada Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 62. US & Canada Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
    Table 63. US & Canada Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
    Table 64. Europe Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 65. Europe Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 66. Europe Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 67. Europe Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 68. Europe Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 69. Europe Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 70. Europe Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 71. Europe Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 72. Europe Rotavirus Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 73. Europe Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 74. Europe Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 75. Europe Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
    Table 76. Europe Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
    Table 77. China Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 78. China Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 79. China Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 80. China Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 81. China Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 82. China Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 83. China Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 84. China Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 85. Asia Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 86. Asia Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 87. Asia Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 88. Asia Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 89. Asia Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 90. Asia Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 91. Asia Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 92. Asia Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 93. Asia Rotavirus Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 94. Asia Rotavirus Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 95. Asia Rotavirus Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 96. Asia Rotavirus Vaccines Sales by Region (2019-2024) & (K Units)
    Table 97. Asia Rotavirus Vaccines Sales by Region (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Type (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Type (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Application (2019-2024) & (K Units)
    Table 103. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Application (2025-2030) & (K Units)
    Table 104. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 107. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
    Table 110. Middle East, Africa and Latin America Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
    Table 111. Bharat Biotech Company Information
    Table 112. Bharat Biotech Description and Major Businesses
    Table 113. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 114. Bharat Biotech Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bharat Biotech Recent Developments
    Table 116. Merck & Co., Inc Company Information
    Table 117. Merck & Co., Inc Description and Major Businesses
    Table 118. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 119. Merck & Co., Inc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Merck & Co., Inc Recent Developments
    Table 121. GlaxoSmithKline plc Company Information
    Table 122. GlaxoSmithKline plc Description and Major Businesses
    Table 123. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 124. GlaxoSmithKline plc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. GlaxoSmithKline plc Recent Developments
    Table 126. Lanzhou Institute of Biological Company Information
    Table 127. Lanzhou Institute of Biological Description and Major Businesses
    Table 128. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 129. Lanzhou Institute of Biological Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Lanzhou Institute of Biological Recent Developments
    Table 131. Bharat Biotech International Limited Company Information
    Table 132. Bharat Biotech International Limited Description and Major Businesses
    Table 133. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 134. Bharat Biotech International Limited Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Bharat Biotech International Limited Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Rotavirus Vaccines Distributors List
    Table 139. Rotavirus Vaccines Customers List
    Table 140. Rotavirus Vaccines Market Trends
    Table 141. Rotavirus Vaccines Market Drivers
    Table 142. Rotavirus Vaccines Market Challenges
    Table 143. Rotavirus Vaccines Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rotavirus Vaccines Product Picture
    Figure 2. Global Rotavirus Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Rotavirus Vaccines Market Share by Type in 2023 & 2030
    Figure 4. Rotarix Product Picture
    Figure 5. RotaTeq Product Picture
    Figure 6. Rotavac Product Picture
    Figure 7. Rotavin-M1 Product Picture
    Figure 8. Lanzhou lamb Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Rotavirus Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Rotavirus Vaccines Market Share by Application in 2023 & 2030
    Figure 12. Adult
    Figure 13. Pediatric
    Figure 14. Rotavirus Vaccines Report Years Considered
    Figure 15. Global Rotavirus Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Rotavirus Vaccines Revenue 2019-2030 (US$ Million)
    Figure 17. Global Rotavirus Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Rotavirus Vaccines Revenue Market Share by Region (2019-2030)
    Figure 19. Global Rotavirus Vaccines Sales 2019-2030 ((K Units)
    Figure 20. Global Rotavirus Vaccines Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Rotavirus Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada Rotavirus Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Rotavirus Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe Rotavirus Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Rotavirus Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 26. China Rotavirus Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Rotavirus Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) Rotavirus Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Rotavirus Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America Rotavirus Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Rotavirus Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Rotavirus Vaccines in the World: Market Share by Rotavirus Vaccines Revenue in 2023
    Figure 33. Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 35. Global Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 36. Global Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 37. Global Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Rotavirus Vaccines Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Rotavirus Vaccines Sales Share by Country (2019-2030)
    Figure 44. U.S. Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 47. Europe Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 49. Europe Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Rotavirus Vaccines Revenue Share by Country (2019-2030)
    Figure 51. Europe Rotavirus Vaccines Sales Share by Country (2019-2030)
    Figure 52. Germany Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 53. France Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 57. China Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 58. China Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 59. China Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 60. China Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 62. Asia Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 64. Asia Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Rotavirus Vaccines Revenue Share by Region (2019-2030)
    Figure 66. Asia Rotavirus Vaccines Sales Share by Region (2019-2030)
    Figure 67. Japan Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 71. India Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Rotavirus Vaccines Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Rotavirus Vaccines Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Rotavirus Vaccines Sales Share by Country (2019-2030)
    Figure 78. Brazil Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Rotavirus Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 83. Rotavirus Vaccines Value Chain
    Figure 84. Rotavirus Vaccines Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions